- Home
- SMLR vs GNFT Comparison
SMLR vs GNFT Comparison
Compare SMLR & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- GNFT
- Stock Information
- Founded
- SMLR 2007
- GNFT 1999
- Country
- SMLR United States
- GNFT France
- Employees
- SMLR N/A
- GNFT N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMLR Health Care
- GNFT Health Care
- Exchange
- SMLR Nasdaq
- GNFT Nasdaq
- Market Cap
- SMLR 289.5M
- GNFT 296.4M
- IPO Year
- SMLR 2014
- GNFT 2019
- Fundamental
- Price
- SMLR $63.63
- GNFT $4.04
- Analyst Decision
- SMLR
- GNFT Strong Buy
- Analyst Count
- SMLR 0
- GNFT 1
- Target Price
- SMLR N/A
- GNFT $13.00
- AVG Volume (30 Days)
- SMLR 1.1M
- GNFT 6.7K
- Earning Date
- SMLR 11-04-2024
- GNFT 09-19-2024
- Dividend Yield
- SMLR N/A
- GNFT N/A
- EPS Growth
- SMLR N/A
- GNFT N/A
- EPS
- SMLR 2.04
- GNFT 0.47
- Revenue
- SMLR $58,938,000.00
- GNFT $86,225,222.00
- Revenue This Year
- SMLR N/A
- GNFT $155.44
- Revenue Next Year
- SMLR N/A
- GNFT N/A
- P/E Ratio
- SMLR $29.79
- GNFT $8.37
- Revenue Growth
- SMLR N/A
- GNFT 175.45
- 52 Week Low
- SMLR $20.88
- GNFT $3.12
- 52 Week High
- SMLR $79.45
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SMLR 64.88
- GNFT 25.53
- Support Level
- SMLR $56.75
- GNFT $4.00
- Resistance Level
- SMLR $63.29
- GNFT $4.41
- Average True Range (ATR)
- SMLR 8.83
- GNFT 0.13
- MACD
- SMLR 0.32
- GNFT -0.04
- Stochastic Oscillator
- SMLR 56.40
- GNFT 3.31
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.